MedTrace Logo

Vibrant Capsule vs. Placebo for Patient Suffering From Constipation

NCT05036369 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-07-09

Study results available
· View outcomes & findings →

Summary

The objectives are to assess the efficacy and safety of Vibrant capsule administered twice a week

Conditions

  • Constipation Chronic Idiopathic

Interventions

DEVICE

Vibrant capsule

Vibrant capsule - Administered twice a week (Monday and Thursday).

DEVICE

Placebo capsule

Placebo Capsule administered twice a week (Monday and Thursday)

Sponsors & Collaborators

  • Vibrant Ltd.

    lead INDUSTRY

Principal Investigators

  • Tal Malina, MBA · Vibrant Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-05
Primary Completion
2022-12-15
Completion
2022-12-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05036369 on ClinicalTrials.gov